245P Palbociclib combined with aromatase inhibitors (AIs) in women ≥75 years with oestrogen receptor positive (ER+ve), human epidermal growth factor receptor 2 negative (HER2-ve) advanced breast cancer: a real-world multicentre UK study

El Badri, S., Tahir, B. orcid.org/0000-0003-0531-3519, Balachandran, K. et al. (16 more authors) (2021) 245P Palbociclib combined with aromatase inhibitors (AIs) in women ≥75 years with oestrogen receptor positive (ER+ve), human epidermal growth factor receptor 2 negative (HER2-ve) advanced breast cancer: a real-world multicentre UK study. In: Annals of Oncology. ESMO Congress 2021, 16-21 Sep 2021, Virtual conference. Elsevier BV , S466-S466.

Metadata

Authors/Creators:
  • El Badri, S.
  • Tahir, B. ORCID logo https://orcid.org/0000-0003-0531-3519
  • Balachandran, K.
  • Bezecny, P.
  • Britton, F.
  • DeSouza, K.
  • Hills, D.
  • Moe, M.
  • Pigott, T.
  • Proctor, A.
  • Shah, Y.
  • Simcock, R.
  • Stansfeld, A.
  • Synowiec, A.
  • Theodoulou, M.
  • Verrill, M.
  • Wadhawan, A.
  • Harper-Wynne, C.
  • Wilson, C.
Copyright, Publisher and Additional Information: © 2021 European Society for Medical Oncology. Published by Elsevier Ltd.
Dates:
  • Published (online): 21 September 2021
  • Published: September 2021
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Human Metabolism (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 31 Aug 2023 11:43
Last Modified: 05 Sep 2023 15:22
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.annonc.2021.08.528
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)